Human epidermal growth factor receptor 2 testing recommendation - In reply

被引：103

作者：

Wolff, Antonio C. ^{[1
]}

Hammond, M. Elizabeth H.

Schwartz, Jared N.

Hayes, Daniel F.

机构：

[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21401 USA

[2] Univ Utah, Sch Med, Salt Lake City, UT USA

[3] Presbyterian Hosp, Charlotte, NC USA

[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 25期

关键词：

D O I：

10.1200/JCO.2007.11.4363

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4021 / 4023

页数：3

共 10 条

[1]

*GEN INC, 2006, HERC PACK INS

[2]

Mass R, 2000, SEMIN ONCOL, V27, P46

[3]

Perez EA, 2002, MAYO CLIN PROC, V77, P148

[4] Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer [J].

Romond, EH ;

Perez, EA ;

Bryant, J ;

Suman, VJ ;

Geyer, CE ;

Davidson, NE ;

Tan-Chiu, E ;

Martino, S ;

Paik, S ;

Kaufman, PA ;

Swain, SM ;

Pisansky, TM ;

Fehrenbacher, L ;

Kutteh, LA ;

Vogel, VG ;

Visscher, DW ;

Yothers, G ;

Jenkins, RB ;

Brown, AM ;

Dakhil, SR ;

Mamounas, EP ;

Lingle, WL ;

Klein, PM ;

Ingle, JN ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1673-1684

[5] 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial [J].

Smith, Ian ;

Procter, Marion ;

D Gelber, Richard ;

Guillaume, Sebastien ;

Feyereislova, Andrea ;

Dowsett, Mitch ;

Goldhirsch, Aron ;

Untch, Michael ;

Mariani, Gabriella ;

Baselga, Jose ;

Kaufmann, Manfred ;

Cameron, David ;

Bell, Richard ;

Bergh, Jonas ;

Coleman, Robert ;

Wardley, Andrew ;

Harbeck, Nadia ;

Lopez, Roberto I. ;

Mallmann, Peter ;

Gelmon, Karen ;

Wilcken, Nicholas ;

Wist, Erik ;

Sanchez Rovira, Pedro ;

Piccart-Gebhart, Martine .

LANCET, 2007, 369 (9555) :29-36

[6] Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: Apparent immunohistochemical false-positives do not get the message [J].

Tubbs, RR ;

Pettay, JD ;

Roche, PC ;

Stoler, MH ;

Jenkins, RB ;

Grogan, TM .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) :2714-2721

[7] Calibration of immunohistochemistry for assessment of HER2 in breast cancer:: results of the French Multicentre GEFPICS Study [J].

Vincent-Salomon, A ;

MacGrogan, G ;

Couturier, J ;

Arnould, L ;

Denoux, Y ;

Fiche, M ;

Jacquemier, J ;

Mathieu, MC ;

Penault-Llorca, F ;

Rigaud, C ;

Roger, P ;

Treilleux, I ;

Vilain, MO ;

Mathoulin-Pélissier, S ;

Le Doussal, V .

HISTOPATHOLOGY, 2003, 42 (04) :337-347

[8] American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer [J].

Wolff, Antonio C. ;

Hammond, M. Elizabeth H. ;

Schwartz, Jared N. ;

Hagerty, Karen L. ;

Allred, D. Craig ;

Cote, Richard J. ;

Dowsett, Mitchell ;

Fitzgibbons, Patrick L. ;

Hanna, Wedad M. ;

Langer, Amy ;

McShane, Lisa M. ;

Paik, Soonmyung ;

Pegram, Mark D. ;

Perez, Edith A. ;

Press, Michael F. ;

Rhodes, Anthony ;

Sturgeon, Catharine ;

Taube, Sheila E. ;

Tubbs, Raymond ;

Vance, Gail H. ;

de Vijver, Marc Van ;

Wheeler, Thomas M. ;

Hayes, Daniel F. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (01) :118-145

[9]

Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO

[10]

← 1 →